Literature DB >> 17884869

Change page: Way forward is not obvious at asthma crossroads.

Syed F Hussain.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17884869      PMCID: PMC1989002          DOI: 10.1136/bmj.39339.481667.3A

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Using a combination inhaler (budesonide plus formoterol) as rescue therapy improves asthma control.

Authors:  Peter J Barnes
Journal:  BMJ       Date:  2007-09-08

2.  Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study.

Authors:  Klaus F Rabe; Tito Atienza; Pál Magyar; Per Larsson; Carin Jorup; Umesh G Lalloo
Journal:  Lancet       Date:  2006-08-26       Impact factor: 79.321

3.  Randomized comparison of strategies for reducing treatment in mild persistent asthma.

Authors:  Stephen P Peters; Nicholas Anthonisen; Mario Castro; Janet T Holbrook; Charles G Irvin; Lewis J Smith; Robert A Wise
Journal:  N Engl J Med       Date:  2007-05-17       Impact factor: 91.245

4.  Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life.

Authors:  David B Price; Angela E Williams; Sally Yoxall
Journal:  Respir Res       Date:  2007-07-04

5.  Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations.

Authors:  P Kuna; M J Peters; A I Manjra; C Jorup; I P Naya; N E Martínez-Jimenez; R Buhl
Journal:  Int J Clin Pract       Date:  2007-03-16       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.